28Feb 2023
Intravenous iron in patients with heart failure and iron deficiency: an updated meta‐analysis

Intravenous iron in patients with heart failure and iron deficiency: an updated meta‐analysis

This article reports on a meta-analysis of randomized trials that investigated the effects of intravenous (IV) iron on clinical outcomes in patients with heart failure (HF) and iron deficiency (ID). The analysis found that IV iron reduces the risk of hospitalizations for heart failure and cardiovascular death, as well as the risk of first hospitalization for heart failure or cardiovascular death. However, the effects on cardiovascular and all-cause mortality were inconclusive. Subgroup analyses showed that patients with lower transferrin saturation may benefit more from IV iron. Overall, the study suggests that IV iron may be a beneficial treatment for patients with HF and ID.

  • #cardiology

Like

Save

Share